TECH vs UTHR · P/E 65, rev $1.22B vs P/E 20, rev $2.88B
Bio-Techne Corp (TECH) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the TECH and UTHR stock pages for the full models.
Not investment advice.